↓ Skip to main content

Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2013
Altmetric Badge

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
4 Mendeley